heterogeneity
-
Fluidigm Corporation and OncoMed Pharmaceuticals Announce Strategic Collaboration
OncoMed Pharmaceuticals and Fluidigm Corporation have announced an initiative to apply the latter’s unique microfluidic tools to the analysis of tumor cell heterogeneity, including cancer stem cells. The collaboration will combine the latter’s mi…
heterogeneity | 22 January 2010
-
Study Shows Heterogeneity in Brain Tumor Cells-of-Origin
A new study led by the National Neuroscience Institute (NNI) and Singapore Institute for Clinical Sciences (SICS), A*STAR shows for the first time that primary brain tumors are caused by a minority group of cells that display a genetic profile disti…
heterogeneity | 01 October 2008
